Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A spinout company from our Department, OxSight, has reported that in a recent UK-wide trial its smart glasses helped sight impaired and blind people to navigate independently, avoid collisions and see in the dark.

The technology was developed in our Department by visual prosthetics researcher Dr Stephen Hicks with support from the Oxford Eye Hospital. Hicks’ team used their understanding of how the brain interprets visual information to develop algorithms that replicate our natural visual interpretation process.

Behind these glasses is ten years of work developing a real-time computer vision algorithm that mimics some of the basic components of human visual perception. The algorithm detects the distance to nearby objects and forms a depth-map which is then enhanced and displayed on the inside of a pair of glasses. It highlights edges and features which make many objects easier to see, especially in low light where many people struggle.
-  Dr Stephen Hicks

The OxSight smart glasses use a unique camera system and computer vision algorithms to detect and highlight objects, separating them from the background in real-time. This allows people with even the lowest amount of sight make better use of their vision in challenging everyday scenarios.

Participants in the trial reported that they were able to describe people standing several meters away and in some cases even recognise their faces and expressions.

OxSight has successfully raised a seed funding round from Oxford angel investor Mr Zhang Jiangong. The company will use the funding to continue to develop the smart glasses. Existing partners include Google, the Royal National Institute of Blind People, the University of Oxford, the NIHR i4i scheme, the Royal Academy of Engineering and Oxford University Innovation. Both Mr Zhang and RTC Innovation, a UK-based technology transfer company have provided valuable support to OxSight over the last 3 years.

Read more from Oxford University Innovation...

Similar stories

Brain immune cells protect neurons in Parkinson’s disease by “nibbling” harmful material

New research, published in Science Translational Medicine, reveals how a specialised population of the brain’s immune cells can remove harmful protein clumps from nerve cells (neurons), pointing to potential new treatments for Parkinson’s disease.

Meeting the neuroscientists at Meeting Minds

Ben Seymour and Masud Husain joined the line up of speakers at this year's Meeting Minds event for Oxford alumni on 19 September

Oxford researchers uncover how Parkinson's disease protein damages brain cells

A new study reveals a key mechanism by which the protein alpha-synuclein, the hallmark of Parkinson's disease, damages neurons (brain cells) by blocking a vital cellular gateway. The results of the study, published in Nature Communications, help to explain how the disease begins and highlights a potential new target for treatment.

New Lancet review calls for urgent action to tackle the growing global threat of encephalitis

The review highlights encephalitis as an urgent global health challenge and calling for faster diagnosis, improved treatments, and strengthened prevention strategies to reduce death and disability worldwide.

Appointment of the new Margaret Ogilvie Professor of Ophthamology

We are delighted to announce that Professor Denize Atan has joined the department as Margaret Ogilvie Professor of Ophthamology and a Consultant in Neuro-ophthalmology at the Oxford Eye Hospital.

Dr Ruxandra Dafinca awarded an Alzheimer’s Society Dementia Research Leader Fellowship

Ruxandra Dafinca is one of 17 early career researchers awarded a fellowship in the 2025/2026 call for her project focused on frontotemporal dementia.